A new patch that delivers ibuprofen directly to the site of pain has been developed, using technology that has the potential for widespread use.
In collaboration with Medherant, researchers from the University of Warwick have worked to develop the first ever ibuprofen patch. The patch has been designed to deliver ibuprofen directly through the skin at the affected area.
The transparent, sticky patch can deliver a consistent dose of ibuprofen to the affected area for up to 12 hours. The patented technology, consisting of a polymer matrix, allows up to 30% of the weight of the patch to be composed of the drug.
Not only has this technology allowed for the development of the ibuprofen patch, but also allows for the future possibility of other drugs to be developed in the form of a patch. This technology would be particularly beneficial for treating conditions such as chronic back pain or arthritis, reducing the need for oral medication that may have side effects associated with extended use.
As stated by the CEO of Medherant, Nigel Davis:
“Our transdermal patch technology expands the range of drugs that can be delivered via skin patches and can significantly increase drug loading capabilities, whilst retaining adhesion and being thin and flexible. Thus our patches provide a better experience for patients, enhance safety and deliver increased efficacy, which will lead to economic benefits to the healthcare system.”
The researchers expect the pain relief patch to be available for purchase in approximately 2 years, with many potential medicinal patches on the horizon.
University of Warwick News Release: “Researchers create World’s first ibuprofen patch – delivering pain relief directly through skin” http://www2.warwick.ac.uk/newsandevents/pressreleases/researchers_create_world146s/ Last Accessed: December 8, 2015
Picture Credit: University of Warwick news release.
Written by Deborah Tallarigo, PhD